These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25853196)

  • 1. Combination therapy with sorafenib and radiofrequency ablation for BCLC stage 0-B1 hepatocellular carcinoma.
    Yang T; Zhang H; Shen YN; Wu MC; Shen F; Schwartz M
    Am J Gastroenterol; 2015 Apr; 110(4):595. PubMed ID: 25853196
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial?
    Facciorusso A; Muscatiello N; Di Leo A; Barone M
    Am J Gastroenterol; 2015 May; 110(5):770-1. PubMed ID: 25942304
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study.
    Feng X; Xu R; Du X; Dou K; Qin X; Xu J; Jia W; Wang Z; Zhao H; Yang S; Guo C; Liu T; Ma K
    Am J Gastroenterol; 2014 Dec; 109(12):1891-9. PubMed ID: 25403366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to Facciorusso et al.
    Feng X; Ma K
    Am J Gastroenterol; 2015 May; 110(5):771-3. PubMed ID: 25942305
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to Yang et al.
    Feng X; Ma K
    Am J Gastroenterol; 2015 Apr; 110(4):595-6. PubMed ID: 25853197
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy.
    Park JG; Park SY; Lee HW
    World J Gastroenterol; 2015 Feb; 21(8):2568-72. PubMed ID: 25741170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.
    Kan X; Jing Y; Wan QY; Pan JC; Han M; Yang Y; Zhu M; Wang Q; Liu KH
    Eur Rev Med Pharmacol Sci; 2015; 19(2):247-55. PubMed ID: 25683938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
    Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
    Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.
    Berretta M; Di Francia R; Tirelli U
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2521-2. PubMed ID: 26221876
    [No Abstract]   [Full Text] [Related]  

  • 11. Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
    Sacco R; Antonucci M; Bargellini I; Marceglia S; Mismas V; Cabibbo G
    Future Oncol; 2015; 11(17):2371-3. PubMed ID: 26270206
    [No Abstract]   [Full Text] [Related]  

  • 12. Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial.
    Giorgio A; Merola MG; Montesarchio L; Merola F; Santoro B; Coppola C; Gatti P; Amendola F; DI Sarno A; Calvanese A; Matteucci P; Giorgio V
    Anticancer Res; 2016 Nov; 36(11):6179-6183. PubMed ID: 27793949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas.
    Liang HY; Lu LG; Hu BS; Li Y; Shao PJ
    Chin Med J (Engl); 2013 Nov; 126(22):4270-6. PubMed ID: 24238511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
    Zhu K; Huang J; Lai L; Huang W; Cai M; Zhou J; Guo Y; Chen J
    Radiology; 2018 Jul; 288(1):300-307. PubMed ID: 29688153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib- or 90Y-loaded resin microsphere radioembolization for locally advanced hepatocellular carcinoma, what should we trust?
    Garin E; Rolland Y; Edeline J
    Liver Int; 2015 Jun; 35(6):1779-80. PubMed ID: 25691322
    [No Abstract]   [Full Text] [Related]  

  • 16. Sorafenib combined with radiofrequency ablation in the treatment of a patient with renal cell carcinoma plus primary hepatocellular carcinoma.
    Gang G; Hongkai Y; Xu Z
    J Cancer Res Ther; 2015; 11(4):1026. PubMed ID: 26881596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    Huang YH; Chen W; Li JP; Chen B; Yang JY
    Chin Med J (Engl); 2013 Jan; 126(2):385-6. PubMed ID: 23324295
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to: "Sorafenib or (90) Y loaded resin microsphere radioembolization for locally-advanced hepatocellular carcinoma, what should we trust?".
    Gramenzi A; Pettinato C; Cappelli A; Mosconi C; Golfieri R; Trevisani F
    Liver Int; 2015 Jun; 35(6):1780-1. PubMed ID: 25778710
    [No Abstract]   [Full Text] [Related]  

  • 19. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
    Waziry R; Gomaa A; Waked I; Dore GJ
    Arab J Gastroenterol; 2018 Mar; 19(1):26-32. PubMed ID: 29506913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAMA PATIENT PAGE. Treatment of Liver Cancer.
    Mokdad AA; Singal AG; Yopp AC
    JAMA; 2016 Jan; 315(1):100. PubMed ID: 26746473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.